Close

News

Senate Draft Cuts to Medicaid and CHIP Criticized

The American Medical Association has spoken out against the budget reconciliation draft from the Senate Finance Committee on June 16. They say that cutting Medicaid and CHIP (the Children's Health Insurance Program) could lead to the shortage of doctors...

Alterations In US Healthcare System Likely in Trump 2.0

Apparently, there is one of the analysts who has gone on to warn of likely disbalance in the US healthcare system because of the election of Donald Trump as the president of the country, especially pointing to the possible...

China’s AI Doctors Revolutionize Healthcare with First AI Hospital

China recently announced a ground-breaking development: the world's first AI hospital with 42 AI doctors on staff. Artificial intelligence is still making impressive advances in healthcare.  This ground-breaking facility, known as the Agent Hospital, was created by Tsinghua University's...

Low-Carbon Inhalers Approved for COPD Treatment in the UK

According to AstraZeneca, the Medicines and Healthcare Products Regulatory Agency(MHRA) has approved a low-carbon version of a triple combination pressurised metred dose (pMDI) inhaler designed for adults with moderate-to-severe chronic obstructive pulmonary disease (COPD). The propellant hydrofluoroalkane-134a (HFA-134a), which has...

Chinese Medtech Companies Reshape Healthcare by Innovation

The worldwide medtech spectrum is undergoing a phenomenal shift, mostly driven due to the meteoric rise when it comes to Chinese companies. The narrative was absolutely simple for decades-China made things cheap. However, that tale is now dangerously outdated....

The Benefits of Virtual GP Insurance: A Game Changer for Modern Healthcare

In today’s fast-paced world, accessing healthcare quickly and efficiently is more important than ever. Virtual GP insurance has emerged as a game-changing solution, allowing patients to consult with a doctor online without the need for in-person visits. With more...

Vaxxas Secures U.S. Patent for HD-MAP Vaccine Technology

Vaxxas, a clinical-stage biotech firm has obtained a new patent from the United States patent office covering proprietary manufacturing technology for its revolutionary immunisation platform, the high-density microarray patch (HD-MAP). Composed of hundreds of microscopic projections shaped into a tiny...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read